Literature DB >> 11426577

Serum factors governing intraerythrocytic development and cell cycle progression of Plasmodium falciparum.

T Mitamura1, K Hanada, E P Ko-Mitamura, M Nishijima, T Horii.   

Abstract

Malaria is clinically manifested only when the human malaria parasites in the genus Plasmodium enter the obligatory intraerythrocytic life cycle. Elucidation for the roles of the serum, the key nutrient, and its components is then deemed essential for thorough understanding of the proliferation of Plasmodium cells at the erythrocytic stage. Fractionation and analysis of serum and its components was performed by chromatography, solvent extraction, and subsequent reconstitution experiments. Only fractions containing serum albumin (SA) from the serum and purified intact bovine serum albumin (BSA) showed comparable growth promoting activity with human serum (HS). Delipidated BSA can only effect parasite growth after reconstitution with lipids extracted from intact BSA. Fatty acid (FA) species in the neutral lipid fraction from intact BSA proved likewise when reconstituted with delipidated BSA. Furthermore, the involved FA species have to come in a pair of one saturated and one unsaturated, with palmitic and oleic acids as the best combination. The results were further substantiated by morphological analysis as well as biochemical analysis of the DNA synthesis during the intraerythrocytic development. This study can be a basis to explore the molecular mechanism of lipid traffic within the parasitized red blood cell (RBC), which can be an important adjunct to the development of drugs for malaria therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11426577     DOI: 10.1016/s1383-5769(00)00048-9

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  21 in total

1.  Rodent and nonrodent malaria parasites differ in their phospholipid metabolic pathways.

Authors:  Sandrine Déchamps; Marjorie Maynadier; Sharon Wein; Laila Gannoun-Zaki; Eric Maréchal; Henri J Vial
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

2.  Fatty acids from Plasmodium falciparum down-regulate the toxic activity of malaria glycosylphosphatidylinositols.

Authors:  Françoise Debierre-Grockiego; Louis Schofield; Nahid Azzouz; Jörg Schmidt; Cristiana Santos de Macedo; Michael A J Ferguson; Ralph T Schwarz
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

Review 3.  Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans.

Authors:  Srinivasan Ramakrishnan; Mauro Serricchio; Boris Striepen; Peter Bütikofer
Journal:  Prog Lipid Res       Date:  2013-07-01       Impact factor: 16.195

4.  Targeting the Lipid Metabolic Pathways for the Treatment of Malaria.

Authors:  Choukri Ben Mamoun; Sean T Prigge; Henri Vial
Journal:  Drug Dev Res       Date:  2010-02       Impact factor: 4.360

5.  A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation.

Authors:  Gabriella Pessi; Guillermo Kociubinski; Choukri Ben Mamoun
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

6.  Disruption of the Plasmodium falciparum PfPMT gene results in a complete loss of phosphatidylcholine biosynthesis via the serine-decarboxylase-phosphoethanolamine-methyltransferase pathway and severe growth and survival defects.

Authors:  William Harold Witola; Kamal El Bissati; Gabriella Pessi; Changan Xie; Paul D Roepe; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

7.  Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy.

Authors:  Kentaro Hanada; Nirianne Marie Q Palacpac; Pamela A Magistrado; Ken Kurokawa; Ganesh Rai; Daiji Sakata; Tomoko Hara; Toshihiro Horii; Masahiro Nishijima; Toshihide Mitamura
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

8.  Oleic acid biosynthesis in Plasmodium falciparum: characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target.

Authors:  Paul Gratraud; Enlli Huws; Brie Falkard; Sophie Adjalley; David A Fidock; Laurence Berry; William R Jacobs; Mark S Baird; Henri Vial; Laurent Kremer
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

9.  Arrest of nuclear division in Plasmodium through blockage of erythrocyte surface exposed ribosomal protein P2.

Authors:  Sudipta Das; Himanish Basu; Reshma Korde; Rita Tewari; Shobhona Sharma
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

10.  Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated.

Authors:  Christina Spry; Cristiano Macuamule; Zhiyang Lin; Kristopher G Virga; Richard E Lee; Erick Strauss; Kevin J Saliba
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.